Pulished Date October, 2018
ID: 1048
Share on
Share on

Middle-East & Africa Ophthalmology Therapeutics Market By Indication (Glaucoma, Dry Eye Syndrome, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration, Macular Edema And Allergic Conjunctivitis) By End User (Hospitals, Eye Clinics, Diagnostic Centres And Patients), And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Pulished: October, 2018
ID: 1048
Pages: 145

Middle-East & Africa Ophthalmology Therapeutics Market was worth $2.81 billion in 2018 and estimated to grow at a CAGR of 8.1%, to reach $4.51 billion by 2023.Ophthalmology is the science associated with the treatment of eye defects and diseases. Recent advancements in genetics and stem cell biology are progressively boosting the potential for ophthalmology therapeutics.

Middle-East & Africa market for Ophthalmology Therapeutics is driven by the growing prevalence for vision impairment. Advancements in the field of medicine is also a key factor driving the growth of the market. Increasing geriatric population around the region along with an increase in the disposable income of the people are some of the other driving factors for the Ophthalmology Therapeutics Market. However, limited awareness about the diseases associated with ophthalmology is the key restraint for the growth of the market. Uncertain reimbursement policies and stringent regulatory framework are some of the other factors restraining the growth of the market.

Middle-East & Africa Ophthalmology Therapeutics market is broadly categorized into Indication and End User. Based on indication Middle-East & Africa Ophthalmology Therapeutics market is segmented into Glaucoma, Dry Eye Syndrome, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration, Macular Edema and Allergic Conjunctivitis. Glaucoma is the largest indication segment accounting for a share of approximately XX% followed by AMD with a share of XX%. On the basis of end user, the market is segmented into Hospitals, Eye Clinics, Diagnostic Centres and Patients. Hospitals account for the largest share of the market with a percentage share of approximately XX% while Diagnostics Centres is the fastest growing segment with a CAGR of XX%.

Based on geography, Middle-East & Africa Ophthalmology Therapeutics market is segmented into Middle-East and Africa. Middle-East is the largest market for Ophthalmology Therapeutics due to high disposable income of the people. Africa is estimated to be the fastest growing region with a CAGR of xx% during the forecast period of 2018-2023.

Some of the major companies covered in the report are Pfizer Inc., Allergan Inc., Alcon Inc., Merck & co. Inc., Roche, Valeant, Regeneron, Santen, Bayer, Senju, Lpath and Eye Gate Pharmaceuticals

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Indication                              

                                5.1.1 Glaucoma

                                5.1.2 Dry Eye Syndrome

                                5.1.3 Diabetic Retinopathy         

                                5.1.4 Retinal Vein Occlusion        

                                5.1.5 Age-Related Macular Degeneration (AMD)

                                5.1.6 Macular Edema    

                                5.1.7 Allergic Conjunctivitis         

                5.2 By End User               

                                5.2.1 Hospitals  

                                5.2.2 Eye Clinics

                                5.2.3 Diagnostic Centers              

                                5.2.4 Patients   

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 Middle-East                                

                6.3 Africa                            

7. Pipeline Product Analysis                                        

                7.1 Overview                    

                7.2 Pipeline Development Landscape                     

                7.3 Molecular Targets in the Pipeline                      

                7.4 Clinical Trials                              

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target               

8.Strategic Analysis                                        

                8.1 PESTLE analysis                         

                                8.1.1 Political     

                                8.1.2 Economic 

                                8.1.3 Social         

                                8.1.4 Technological         

                                8.1.5 Legal          

                                8.1.6 Environmental      

                8.2 Porter’s Five analysis                              

                                8.2.1 Bargaining Power of Suppliers        

                                8.2.2 Bargaining Power of Consumers    

                                8.2.3 Threat of New Entrants     

                                8.2.4 Threat of Substitute Products and Services

                                8.2.5 Competitive Rivalry within the Industry      

9.Market Leaders' Analysis                                          

                9.1 Allergan, Inc.                              

                                9.1.1 Overview

                                9.1.2 Product Analysis   

                                9.1.3 Financial analysis  

                                9.1.4 Recent Developments       

                                9.1.5 SWOT analysis       

                                9.1.6 Analyst View          

                9.2 Merck & Co Inc                         

                9.3 Pfizer                            

                9.4 Roche                           

                9.5 Novartis (Alcon)                       

                9.6 Valeant                        

                9.7 Regeneron                 

                9.8 Santen                         

                9.9 Bayer                            

                9.10 Senju                          

                9.11 Lpath                          

                9.12 Eye Gate Pharmaceuticals                 

10.Competitive Landscape                                          

                10.1 Market share analysis                          

                10.2 Merger and Acquisition Analysis                     

                10.3 Agreements, collaborations and Joint Ventures                       

                10.4 New Product Launches                       

11.Market Outlook & Investment Opportunities                               

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Ophthalmology Therapeutics Market By Region, From 2018-2023 (USD Bllion)
  2. Middle East & Africa Ophthalmology Therapeutics Market By Indication, From 2018-2023 (USD Bllion)
  3. Middle East & Africa Glaucoma Market By Region, From 2018-2023 (USD Bllion)
  4. Middle East & Africa Dry Eye Syndrome Market By Region, From 2018-2023 (USD Bllion)
  5. Middle East & Africa Diabetic Retinopathy Market By Region, From 2018-2023 (USD Bllion)
  6. Middle East & Africa Retinal Vein Occlusion Market By Region, From 2018-2023 (USD Bllion)
  7. Middle East & Africa Age-Related Macular Degeneration (AMD) Market By Region, From 2018-2023 (USD Bllion)
  8. Middle East & Africa Macular Edema Market By Region, From 2018-2023 (USD Bllion)
  9. Middle East & Africa Allergic Conjunctivitis Market By Region, From 2018-2023 (USD Bllion)
  10. Middle East & Africa Ophthalmology Therapeutics Market By End-User, From 2018-2023 (USD Bllion)
  11. Middle East & Africa Hospitals Market By Region, From 2018-2023 (USD Bllion)
  12. Middle East & Africa Eye Clinics Market By Region, From 2018-2023 (USD Bllion)
  13. Middle East & Africa Diagnostic Centers Market By Region, From 2018-2023 (USD Bllion)
  14. Middle East & Africa Patients Market By Region, From 2018-2023 (USD Bllion)
  15. Middle East Ophthalmology Therapeutics Market By Indication, From 2018-2023 (USD Bllion)
  16. Middle East Ophthalmology Therapeutics Market By End-User, From 2018-2023 (USD Bllion)
  17. Africa Ophthalmology Therapeutics Market By Indication, From 2018-2023 (USD Bllion)
  18. Africa Ophthalmology Therapeutics Market By End-User, From 2018-2023 (USD Bllion)

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients